Prevention of myelosuppression does not improve the therapeutic efficacy of chemo-immunotherapy.

Angela J. Lumsden, Peter H. van der Meide, Jim Codde(The University of Notre Dame Australia), Bruce N. Gray(Royal Perth Hospital)
PubMed
December 16, 1992
Cited by 2

Related Papers

The quanitification of drug caused morbidity and mortality in Australia: Part 1
|UWA Profiles and Research Repository (University of Western Australia)|1995|470
Poor Long-Term Survival in Patients With Moderate Aortic Stenosis
|Journal of the American College of Cardiology|2019|418
REGRESSION OF LIVER METASTASES FOLLOWING TREATMENT WITH YTTRIUM‐90 MICROSPHERES
|Australian and New Zealand Journal of Surgery|1992|145
Threshold of Pulmonary Hypertension Associated With Increased Mortality
|Journal of the American College of Cardiology|2019|132
Effectiveness of peers in delivering programs or motivating older people to increase their participation in physical activity: Systematic review and meta-analysis
|Journal of Sports Sciences|2017|113